Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)
- Status
- COMPLETED
- Phase
- NA
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)
- Status
- COMPLETED
- Phase
- PHASE4
Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block
- Status
- COMPLETED
- Phase
- PHASE4
Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Single, Low-dose Dexamethasone in Patients After Total Knee Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Dexamethasone and Methylprednisolone on Pain, Swelling and Trismus After Third Molar Surgery
- Status
- COMPLETED
- Phase
- NA
A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
- Status
- COMPLETED
- Phase
- PHASE4
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma
- Status
- UNKNOWN
- Phase
- PHASE2
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3